Established in 2012, CANbridge is a global biopharmaceutical company leveraging its foundation in China to develop and deliver life-changing therapeutics for rare diseases and rare oncology worldwide.
CANbridge creates a bridge between the best therapeutic products selected from around the world for their ability to address unmet needs and the fast-growing Chinese market.